Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | PLA2G2D | Human | 1,2-dimethylhydrazine | increases expression | ISO | Pla2g2d (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of PLA2G2D mRNA | CTD | PMID:22206623 | PLA2G2D | Human | 17alpha-ethynylestradiol | affects expression | ISO | Pla2g2d (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of PLA2G2D mRNA | CTD | PMID:17555576 | PLA2G2D | Human | 17alpha-ethynylestradiol | increases expression | ISO | Pla2g2d (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of PLA2G2D mRNA | CTD | PMID:17942748 | PLA2G2D | Human | 17beta-estradiol | multiple interactions | ISO | Pla2g2d (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLA2G2D mRNA | CTD | PMID:32741896 | PLA2G2D | Human | 17beta-estradiol 3-benzoate | multiple interactions | ISO | Pla2g2d (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLA2G2D mRNA | CTD | PMID:32741896 | PLA2G2D | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Pla2g2d (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PLA2G2D mRNA | CTD | PMID:21215274 | PLA2G2D | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Pla2g2d (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PLA2G2D mRNA | CTD | PMID:33387578 | PLA2G2D | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Pla2g2d (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of PLA2G2D mRNA | CTD | PMID:34747641 | PLA2G2D | Human | 3,3',4,4',5-pentachlorobiphenyl | decreases expression | ISO | Pla2g2d (Rattus norvegicus) | 6480464 | 3 more ... | CTD | PMID:23196670 | PLA2G2D | Human | 6-propyl-2-thiouracil | decreases expression | ISO | Pla2g2d (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of PLA2G2D mRNA | CTD | PMID:24780913 | PLA2G2D | Human | 6-propyl-2-thiouracil | increases expression | ISO | Pla2g2d (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of PLA2G2D mRNA | CTD | PMID:30047161 | PLA2G2D | Human | acetamide | increases expression | ISO | Pla2g2d (Rattus norvegicus) | 6480464 | acetamide results in increased expression of PLA2G2D mRNA | CTD | PMID:31881176 | PLA2G2D | Human | acrylamide | decreases expression | ISO | Pla2g2d (Rattus norvegicus) | 6480464 | Acrylamide results in decreased expression of PLA2G2D mRNA | CTD | PMID:28959563 | PLA2G2D | Human | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of PLA2G2D gene | CTD | PMID:27153756 | PLA2G2D | Human | amitrole | increases expression | ISO | Pla2g2d (Rattus norvegicus) | 6480464 | Amitrole results in increased expression of PLA2G2D mRNA | CTD | PMID:30047161 | PLA2G2D | Human | aristolochic acids | increases expression | ISO | Pla2g2d (Rattus norvegicus) | 6480464 | Aristolochic Acids results in increased expression of PLA2G2D mRNA | CTD | PMID:21834575 | PLA2G2D | Human | benzo[a]pyrene | decreases expression | ISO | Pla2g2d (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of PLA2G2D mRNA | CTD | PMID:21569818 | PLA2G2D | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of PLA2G2D promoter | CTD | PMID:27901495 | PLA2G2D | Human | benzo[b]fluoranthene | increases expression | ISO | Pla2g2d (Mus musculus) | 6480464 | benzo(b)fluoranthene results in increased expression of PLA2G2D mRNA | CTD | PMID:26377693 | PLA2G2D | Human | bisphenol A | affects expression | ISO | Pla2g2d (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of PLA2G2D mRNA | CTD | PMID:25181051 | PLA2G2D | Human | bisphenol A | increases expression | ISO | Pla2g2d (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of PLA2G2D mRNA | CTD | PMID:30816183 more ... | PLA2G2D | Human | cadmium atom | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PLA2G2D mRNA | CTD | PMID:35301059 | PLA2G2D | Human | cadmium dichloride | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PLA2G2D mRNA | CTD | PMID:35301059 | PLA2G2D | Human | crocidolite asbestos | decreases expression | EXP | | 6480464 | Asbestos and Crocidolite results in decreased expression of PLA2G2D mRNA | CTD | PMID:29523930 | PLA2G2D | Human | dimethylarsinic acid | multiple interactions | ISO | Pla2g2d (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PLA2G2D mRNA | CTD | PMID:34876320 | PLA2G2D | Human | fenvalerate | increases expression | ISO | Pla2g2d (Rattus norvegicus) | 6480464 | fenvalerate results in increased expression of PLA2G2D mRNA | CTD | PMID:30307764 | PLA2G2D | Human | genistein | decreases expression | ISO | Pla2g2d (Rattus norvegicus) | 6480464 | Genistein results in decreased expression of PLA2G2D mRNA | CTD | PMID:23160963 | PLA2G2D | Human | gentamycin | decreases expression | ISO | Pla2g2d (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of PLA2G2D mRNA | CTD | PMID:33387578 | PLA2G2D | Human | glycidol | increases expression | ISO | Pla2g2d (Rattus norvegicus) | 6480464 | glycidol results in increased expression of PLA2G2D mRNA | CTD | PMID:24915197 | PLA2G2D | Human | hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of PLA2G2D mRNA | CTD | PMID:21179406 | PLA2G2D | Human | irinotecan | affects expression | ISO | Pla2g2d (Rattus norvegicus) | 6480464 | Irinotecan affects the expression of PLA2G2D mRNA | CTD | PMID:20097248 | PLA2G2D | Human | lead diacetate | decreases expression | ISO | Pla2g2d (Mus musculus) | 6480464 | lead acetate results in decreased expression of PLA2G2D mRNA | CTD | PMID:22613225 | PLA2G2D | Human | manganese(II) chloride | increases methylation | ISO | Pla2g2d (Rattus norvegicus) | 6480464 | manganese chloride results in increased methylation of PLA2G2D gene | CTD | PMID:28801915 | PLA2G2D | Human | manganese(II) chloride | decreases expression | ISO | Pla2g2d (Rattus norvegicus) | 6480464 | manganese chloride results in decreased expression of PLA2G2D mRNA | CTD | PMID:28801915 | PLA2G2D | Human | methimazole | increases expression | ISO | Pla2g2d (Rattus norvegicus) | 6480464 | Methimazole results in increased expression of PLA2G2D mRNA | CTD | PMID:30047161 | PLA2G2D | Human | methylarsonic acid | multiple interactions | ISO | Pla2g2d (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PLA2G2D mRNA | CTD | PMID:34876320 | PLA2G2D | Human | N-methyl-4-phenylpyridinium | decreases expression | ISO | Pla2g2d (Rattus norvegicus) | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of PLA2G2D mRNA | CTD | PMID:28801915 | PLA2G2D | Human | ozone | multiple interactions | ISO | Pla2g2d (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PLA2G2D mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of PLA2G2D mRNA | CTD | PMID:34911549 | PLA2G2D | Human | paclitaxel | increases expression | ISO | Pla2g2d (Rattus norvegicus) | 6480464 | Paclitaxel results in increased expression of PLA2G2D mRNA | CTD | PMID:18754875 | PLA2G2D | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of PLA2G2D mRNA | CTD | PMID:22230336 | PLA2G2D | Human | paracetamol | decreases expression | ISO | Pla2g2d (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of PLA2G2D mRNA | CTD | PMID:33387578 | PLA2G2D | Human | paraquat | decreases expression | ISO | Pla2g2d (Rattus norvegicus) | 6480464 | Paraquat results in decreased expression of PLA2G2D mRNA | CTD | PMID:32680482 | PLA2G2D | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of PLA2G2D mRNA | CTD | PMID:23557933 | PLA2G2D | Human | rotenone | decreases expression | ISO | Pla2g2d (Rattus norvegicus) | 6480464 | Rotenone results in decreased expression of PLA2G2D mRNA | CTD | PMID:28374803 | PLA2G2D | Human | silicon dioxide | increases expression | ISO | Pla2g2d (Rattus norvegicus) | 6480464 | Silicon Dioxide results in increased expression of PLA2G2D mRNA | CTD | PMID:32721576 | PLA2G2D | Human | sodium arsenate | multiple interactions | ISO | Pla2g2d (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PLA2G2D mRNA | CTD | PMID:34876320 | PLA2G2D | Human | sodium arsenite | multiple interactions | ISO | Pla2g2d (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PLA2G2D mRNA | CTD | PMID:34876320 | PLA2G2D | Human | tamoxifen | affects expression | ISO | Pla2g2d (Mus musculus) | 6480464 | Tamoxifen affects the expression of PLA2G2D mRNA | CTD | PMID:17555576 | PLA2G2D | Human | testosterone | multiple interactions | ISO | Pla2g2d (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLA2G2D mRNA | CTD | PMID:32741896 | PLA2G2D | Human | tetracycline | decreases expression | ISO | Pla2g2d (Mus musculus) | 6480464 | Tetracycline results in decreased expression of PLA2G2D mRNA | CTD | PMID:16917069 | PLA2G2D | Human | tetraphene | increases expression | ISO | Pla2g2d (Mus musculus) | 6480464 | benz(a)anthracene results in increased expression of PLA2G2D mRNA | CTD | PMID:26377693 | PLA2G2D | Human | thioacetamide | increases expression | ISO | Pla2g2d (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of PLA2G2D mRNA | CTD | PMID:34492290 | PLA2G2D | Human | titanium dioxide | increases expression | ISO | Pla2g2d (Mus musculus) | 6480464 | titanium dioxide results in increased expression of PLA2G2D mRNA | CTD | PMID:23557971 | PLA2G2D | Human | vinclozolin | affects expression | ISO | Pla2g2d (Rattus norvegicus) | 6480464 | vinclozolin affects the expression of PLA2G2D mRNA | CTD | PMID:19015723 | |